재택 투석 시스템 시장 - 세계 예측(2026-2032년)

The Home Dialysis Systems Market is projected to grow by USD 56.28 billion at a CAGR of 10.91% by 2032.

Home Dialysis Systems Executive Summary

Home dialysis systems are becoming a critical pillar of renal replacement therapy as health systems respond to rising chronic kidney disease burden, increasing end-stage kidney disease prevalence, aging populations, and the need for patient-centered care delivery. Home hemodialysis and peritoneal dialysis enable eligible patients to conduct treatment outside traditional in-center settings, supported by compact dialysis machines, automated peritoneal dialysis cyclers, remote monitoring tools, disposable consumables, water treatment components, vascular access management, and telehealth-enabled clinical oversight. The shift toward home-based kidney care is supported by clinical evidence and clinical practice guidelines showing that appropriately selected and trained patients can achieve safe, effective therapy at home while gaining flexibility, reduced travel burden, and improved treatment autonomy. For providers and payers, home dialysis systems align with priorities around care decentralization, dialysis capacity management, infection risk mitigation, and long-term management of chronic disease. The sector is shaped by regulatory requirements for medical device safety, dialysis water quality, biocompatible materials, human factors engineering, cybersecurity, training protocols, reimbursement design, and caregiver support. As kidney care evolves from clinic-centric treatment toward connected, personalized, and outcomes-oriented models, home dialysis systems are increasingly positioned at the intersection of medical device innovation, digital health, nephrology services, and value-based care.

Transformative Shifts in the Home Dialysis Landscape

The home dialysis systems landscape is being transformed by the convergence of miniaturized device design, remote patient monitoring, tele-nephrology, simplified user interfaces, and stronger policy focus on home-based care. Historically, dialysis delivery depended heavily on in-center infrastructure, fixed treatment schedules, and frequent patient transportation. Today, patient-friendly cyclers, connected hemodialysis platforms, automated alarms, cloud-enabled treatment data, and improved training models are supporting broader use among suitable patients. Clinical practice is also shifting toward shared decision-making, with nephrologists, nurses, patients, and caregivers assessing modality choice based on medical suitability, lifestyle needs, home environment, health literacy, and support systems. Another important transformation is the growing role of integrated kidney care programs that combine education, predialysis planning, access preparation, nutrition management, medication support, and digital follow-up. Supply resilience and consumable logistics have become more important as home therapy depends on reliable delivery of dialysate, cartridges, tubing, filters, disinfectants, and emergency support. Regulatory agencies and clinical guidelines continue to emphasize device usability, patient safety, infection prevention, and training competency, encouraging manufacturers and care networks to design solutions that reduce setup complexity and treatment errors. These shifts are making home dialysis systems more scalable, connected, and aligned with modern chronic care pathways.

Cumulative Impact of Artificial Intelligence on Home Dialysis Systems

Artificial intelligence is beginning to influence home dialysis systems through treatment personalization, remote surveillance, workflow automation, predictive alerts, and clinical decision support. AI-enabled analytics can help identify treatment deviations, missed sessions, unusual ultrafiltration patterns, fluid balance concerns, access-related complications, and patient-reported symptom trends when integrated with connected devices and electronic health records. In home peritoneal dialysis, algorithmic tools can support monitoring of dwell patterns, drain volumes, alarms, and therapy adherence, while in home hemodialysis they can help assess machine performance, pressure trends, conductivity events, and treatment consistency. For clinicians, AI may reduce data overload by prioritizing patients requiring intervention and enabling earlier outreach before complications escalate. For patients, intelligent interfaces can support guided setup, troubleshooting, reminders, and education reinforcement, though these tools must be validated for safety, transparency, usability, and equity. The cumulative impact of AI will depend on high-quality interoperable data, secure connectivity, privacy compliance, bias mitigation, and clear clinical governance. AI should augment rather than replace nephrology expertise, particularly because home dialysis decisions involve complex factors such as residual kidney function, comorbidities, vascular access status, infection risk, caregiver availability, and patient preference. When responsibly deployed, AI can strengthen home dialysis by improving continuity of care, enabling proactive monitoring, reducing preventable interruptions, and supporting more individualized kidney replacement therapy.

Key Regional Insights Across Global Home Dialysis Systems

Asia-Pacific is experiencing strong structural drivers for home dialysis systems due to large populations, rising diabetes and hypertension prevalence, expanding chronic kidney disease screening, and increasing pressure on urban dialysis infrastructure. Countries with mature healthcare systems in the region emphasize technology-enabled home care, while emerging economies are focused on improving access, affordability, training, and supply logistics. North America remains a highly developed environment for home dialysis adoption, supported by established nephrology networks, reimbursement mechanisms that encourage home modalities, patient education initiatives, and growing use of remote monitoring and telehealth. The United States and Canada also place increasing emphasis on value-based kidney care, modality education, and earlier transition planning. Latin America is advancing gradually as public and private systems address uneven dialysis access, geographic barriers, and cost constraints; home peritoneal dialysis has particular relevance where travel distances and center capacity limit frequent in-center treatment. Europe benefits from strong clinical governance, national kidney registries, quality standards, and broad acceptance of patient choice in modality planning, with Western and Northern European systems generally better positioned for digitally supported home therapy than some resource-constrained areas. The Middle East is seeing growing interest in home dialysis systems as governments invest in specialty care, chronic disease management, and healthcare modernization, particularly where diabetes-related kidney disease is a major concern. Africa faces the greatest access challenges, including limited nephrology workforce, affordability constraints, infrastructure gaps, and supply chain complexity; however, home dialysis can be strategically relevant in select urban and referral settings when supported by reliable consumables, infection control education, and patient follow-up systems.

Key Group Insights Shaping Home Dialysis Adoption

ASEAN countries present a diverse home dialysis environment, with advanced urban centers increasingly adopting automated peritoneal dialysis and connected care while lower-resource settings prioritize essential access, clinician training, and affordability. The GCC is shaped by high chronic disease prevalence, substantial healthcare investment, and modernization of specialty care pathways, making home dialysis systems relevant for reducing hospital dependence and supporting patient convenience where strong logistics and nursing education are available. The European Union provides a favorable framework for home dialysis through medical device regulation, patient safety standards, cross-country clinical collaboration, and policies supporting integrated chronic care, although adoption varies by reimbursement design, workforce capacity, and national kidney care practices. BRICS countries collectively represent large kidney disease burdens and highly varied infrastructure; China, India, and Brazil face scale and access challenges, while Russia and South Africa show differing needs related to geography, payer structures, and specialty workforce distribution. G7 countries generally demonstrate higher readiness for home dialysis systems due to established reimbursement pathways, device regulation, digital health infrastructure, nephrology expertise, and patient support programs, though workforce shortages and health equity gaps remain persistent barriers. NATO member states overlap significantly with advanced healthcare systems in North America and Europe, where resilient medical supply chains, cybersecurity expectations, and continuity-of-care planning are increasingly relevant to connected home dialysis devices and remote clinical monitoring.

Key Country Insights for Home Dialysis Systems

The United States is one of the most policy-influenced home dialysis environments, with kidney care reforms, reimbursement incentives, telehealth adoption, and patient modality education supporting broader use of home hemodialysis and peritoneal dialysis. Canada benefits from publicly funded healthcare structures, provincial renal programs, and strong clinical oversight, though geography makes remote support and supply delivery especially important. Mexico and Brazil face growing chronic kidney disease needs alongside access disparities, making home dialysis relevant where training, reimbursement, and consumable distribution can be reliably coordinated. The United Kingdom supports home-based renal therapy through structured kidney care pathways and national health service planning, while Germany, France, Italy, and Spain combine mature nephrology services with varying reimbursement and regional care models that influence the pace of home dialysis adoption. Russia's large geography creates a role for decentralized kidney care, but infrastructure and regional resource variation affect implementation. China is expanding kidney care capacity amid rising diabetes and hypertension, with digital health and domestic medical device development supporting future home dialysis integration. India has substantial unmet renal care needs, and home peritoneal dialysis can improve access for suitable patients, although affordability, awareness, infection prevention training, and supply reliability remain essential. Japan has a highly developed healthcare system and aging population, with strong quality standards and growing relevance for home-based chronic care. Australia's geography strongly supports remote dialysis models, including home therapy for rural and Indigenous communities when culturally appropriate support is available. South Korea combines advanced medical infrastructure, digital connectivity, and high chronic disease management capacity, positioning it for continued development of connected home dialysis systems.

Actionable Recommendations for Home Dialysis Industry Leaders

Industry leaders should prioritize user-centered design, simplified setup, multilingual training, remote monitoring interoperability, and robust patient safety features to increase confidence among patients, caregivers, and clinicians. Device developers should invest in compact platforms, automated disinfection, intuitive alarms, reduced manual handling, reliable connectivity, and cybersecurity-by-design. Care providers should strengthen modality education before dialysis initiation, standardize home assessments, improve nurse-led training, and build rapid-response support for alarms, access issues, supply disruptions, and infection concerns. Payers and health systems should align reimbursement with outcomes, training quality, telehealth support, consumable logistics, and caregiver burden reduction. Manufacturers and service partners should improve supply chain resilience for cartridges, dialysate, tubing, filters, and spare parts, particularly in regions with difficult last-mile delivery. Stakeholders should also expand evidence generation through real-world studies that evaluate quality of life, hospitalization, technique survival, adherence, patient experience, and health equity outcomes without relying solely on utilization metrics. AI and connected device strategies should include transparent validation, clinician oversight, data privacy compliance, and integration with existing renal information systems. To improve equitable access, leaders should design programs for older adults, rural populations, low-literacy users, and patients with limited caregiver support while ensuring that home dialysis remains a choice based on clinical suitability and patient preference.

Research Methodology for Home Dialysis Systems Analysis

This executive summary is developed using a secondary research approach grounded in verified clinical, regulatory, and public health sources relevant to home dialysis systems. The methodology considers evidence from nephrology guidelines, renal registry publications, public health agencies, medical device regulatory frameworks, peer-reviewed literature, reimbursement policy documents, healthcare infrastructure assessments, and clinical best practices for home hemodialysis and peritoneal dialysis. The analysis evaluates demand drivers such as chronic kidney disease prevalence, diabetes and hypertension burden, aging demographics, dialysis access challenges, telehealth adoption, and patient-centered care priorities. It also reviews supply-side factors including device usability, consumables logistics, remote monitoring capabilities, safety standards, training requirements, cybersecurity expectations, and post-market surveillance. Regional, group, and country insights are synthesized by comparing healthcare system maturity, reimbursement structures, nephrology workforce capacity, geographic access barriers, chronic disease patterns, digital health readiness, and regulatory environments. The research deliberately excludes market estimation, market sizing, market share, and forecasting, focusing instead on qualitative and data-backed indicators that explain adoption readiness, clinical relevance, and strategic direction in home dialysis systems.

Conclusion: The Future of Home Dialysis Systems

Home dialysis systems are moving from a niche modality toward a central component of modern kidney care as healthcare systems pursue safer, more flexible, and more patient-centered treatment models. The strongest momentum is visible where reimbursement, nephrology training, remote monitoring, supply logistics, and patient education are aligned. Home hemodialysis and peritoneal dialysis can reduce dependency on in-center treatment for eligible patients while improving autonomy and supporting continuity of care, but successful implementation requires rigorous clinical selection, comprehensive training, reliable consumable delivery, infection prevention, and responsive technical support. Artificial intelligence and connected platforms are expected to enhance monitoring and personalization, provided they are implemented with transparency, validation, privacy protection, and clinician governance. Regional differences remain significant: advanced healthcare systems are focused on digital integration and outcomes-based care, while emerging markets prioritize affordability, access, and infrastructure reliability. Industry leaders that combine safe device innovation, evidence-based care models, equitable access strategies, and interoperable digital ecosystems will be best positioned to support the next phase of home-based renal replacement therapy.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Home Dialysis Systems Market, by Modality

• 7.1. Introduction
• 7.2. Home Hemodialysis
  • 7.2.1. Conventional Hemodialysis
  • 7.2.2. Nocturnal Hemodialysis
  • 7.2.3. Short Daily Hemodialysis
• 7.3. Peritoneal Dialysis
  • 7.3.1. Automated Peritoneal Dialysis
  • 7.3.2. Continuous Ambulatory Peritoneal Dialysis

8. Home Dialysis Systems Market, by Product Type

• 8.1. Introduction
• 8.2. Dialysis Machines
• 8.3. Dialysate Delivery Systems
  • 8.3.1. Acid Concentrates
  • 8.3.2. Bicarbonate Solutions
• 8.4. Dialysate Solutions
• 8.5. Blood Tubing Sets
• 8.6. Dialyzers

9. Home Dialysis Systems Market, by System Type

• 9.1. Introduction
• 9.2. Portable Systems
• 9.3. Wearable Systems
• 9.4. Stationary Systems
• 9.5. Compact Systems

10. Home Dialysis Systems Market, by Therapy Type

• 10.1. Introduction
• 10.2. Acute Home Dialysis
• 10.3. Chronic Home Dialysis

11. Home Dialysis Systems Market, by Patient Type

• 11.1. Introduction
• 11.2. Adult
• 11.3. Pediatric
• 11.4. Geriatric

12. Home Dialysis Systems Market, by End User

• 12.1. Introduction
• 12.2. Home Care Settings
• 12.3. Ambulatory Care Settings
• 12.4. Long Term Care Facilities
• 12.5. Dialysis Centers
• 12.6. Hospitals

13. Home Dialysis Systems Market, by Distribution Channel

• 13.1. Introduction
• 13.2. Online
• 13.3. Retail

14. Home Dialysis Systems Market, by Region

• 14.1. Asia-Pacific
• 14.2. North America
• 14.3. Latin America
• 14.4. Europe
• 14.5. Middle East
• 14.6. Africa

15. Home Dialysis Systems Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Home Dialysis Systems Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Share Analysis, 2025
• 17.2. FPNV Positioning Matrix, 2025
• 17.3. Market Concentration Analysis, 2025
  • 17.3.1. Concentration Ratio (CR)
  • 17.3.2. Herfindahl Hirschman Index (HHI)
• 17.4. Recent Developments & Impact Analysis, 2025
• 17.5. Product Portfolio Analysis, 2025
• 17.6. Benchmarking Analysis, 2025

18. Company Profiles

• 18.1. Allmed Medical Care Holdings Limited
• 18.2. Asahi Kasei Corporation
• 18.3. AWAK Technologies
• 18.4. B. Braun Melsungen AG
• 18.5. Baxter International Inc.
• 18.6. Becton, Dickinson and Company
• 18.7. Cook Medical Inc.
• 18.8. DaVita Inc.
• 18.9. Dialife SA
• 18.10. Diaverum AB
• 18.11. Fresenius Medical Care AG & Co. KGaA
• 18.12. Huaren Pharmaceutical Co. Ltd.
• 18.13. JMS Co. Ltd.
• 18.14. Kawasumi Laboratories Inc.
• 18.15. Medionics International Inc.
• 18.16. Medtronic plc
• 18.17. Newsol Technologies Inc.
• 18.18. Nikkiso Co. Ltd.
• 18.19. Nipro Corporation
• 18.20. Outset Medical Inc.
• 18.21. Poly Medicure Limited
• 18.22. Quanta Dialysis Technologies
• 18.23. Teleflex Incorporated
• 18.24. Terumo Corporation
• 18.25. Toray Medical Co. Ltd.
• 18.26. Utah Medical Products Inc.